Literaturverzeichnis

Adam, E.; Melnick, J. L.; Probtsfield, J. L.; Petrie, B. L.; Burek, J.; Bailey, K. R.; McCollum, C. H. und DeBakey, M. E. (1987): High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis, Lancet (Band 2), Nr. 8554, Seite 291-3.Adam, E.; Melnick, J. L.; Probtsfield, J. L.; Petrie, B. L.; Burek, J.; Bailey, K. R.; McCollum, C. H. und DeBakey, M. E. (1987): High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis, Lancet (Band 2), Nr. 8554, Seite 291-3.

Adler, S. P.; Baggett, J. und McVoy, M. (1985): Transfusion-associated cytomegalovirus infections in seropositive cardiac surgery patients, Lancet (Band 2), Nr. 8458, Seite 7437.

Ahlfors K., Ivarsson SA. (1985): Cytomegalovirus in breast milk of Swedish milk donors, Scand J Infect Dis (Band 17), Seite 11-13.

Ahlfors K., Ivarsson SA., Harris S. (1999): Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in literature, Scand J Infect Dis (Band 31), Seite 443-457.

Alexandrova, M. und Macho, L. (1983): Glucocorticoids in human, cow and rat milk, Endocrinol Exp (Band 17), Nr. 3-4, Seite 183-9.

Alford, C. (1991): Breast milk transmission of cytomegalovirus (CMV) infection, Adv Exp Med Biol (Band 310), Seite 293-9.

Anderson KS., Amos CS. Boppana S., Pass R (1996): Ocular abnormalities in congenital cytomegalovirus infection, J. Am. Optom. Assoc. (Band 67), Seite 273-8.

Archimandritis, A.; Markoulatos, P.; Tjivras, M.; Alexiou, A.; Kordossi, A.; Kordossis, T. und Fertakis, A. (1992): Herpes simplex virus types 1 and 2 and cytomegalovirus in peptic ulcer disease and non-ulcer dyspepsia, Hepatogastroenterology (Band 39), Nr. 6, Seite 540-1.

Asadullah, K.; Prosch, S.; Audring, H.; Buttnerova, I.; Volk, H. D.; Sterry, W. und Docke, W. D. (1999): A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression, Br J Dermatol (Band 141), Nr. 1, Seite 94-102.

Asanuma H., Numazaki K., Nagata N., Hotsubo T., Horino K., Chiba S. (1996): Role of milk whey in the transmission of human cxytomegalovirus infection by breast milk, Microbiol Immunol (Band 40), Seite 201-4.

Baldanti F., Sarasini A., Furione M., Gatti M., Comolli G., Revello MG., Gerna G. (1998): Coinfection of the immunocompromised but not the immunocompetent host by multiple human cytomegalovirus, Arch of Virology (Band 143), Seite 1701-1709.

Bauer H., Ting Y., Greer C., Chambers J., Cathy MD. et al. (1991): Genital Human Papillomavirus Infection in Female University Students as determined by a PCR-based Method, JAMA (Band 265), Nr. 4, Seite 472-76.

Beutler T., Hoflich C., Stevens PA., Kruger DH., Prosch S. (2003): Downregulation of the epidermal growth factor receptor by human cytomegalovirus infection in human fetal lung fibroblasts, Am J Respir Cell Mol Biol (Band 28), Nr. 1, Seite 86-94.

Bianco, C.; Wechselberger, C.; Ebert, A.; Khan, N. I.; Sun, Y. und Salomon, D. S. (2001): Identification of Cripto-1 in human milk, Breast Cancer Res Treat (Band 66), Nr. 1, Seite 1-7.

Boppana, S. B.; Pass, R. F.; Britt, W. J.; Stagno, S. und Alford, C. A. (1992): Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality, Pediatr Infect Dis J (Band 11), Nr. 2, Seite 93-9.

Boshart, M.; Weber, F.; Jahn, G.; Dorsch-Hasler, K.; Fleckenstein, B. und Schaffner, W. (1985): A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus, Cell (Band 41), Nr. 2, Seite 521-30.

Bradford MM. (1976): A rapid and sensitive Method for the quantitation of Microgam Quantities of Protein Utilizing the Principle of Protein-Dye-Binding, Anal Biochem (Band 72), Seite 248-54.

Bryant P., Morley C., Garland S., Curtis N. (2002): Cytomegalovirus transmission from breast milk in premature babies: does it matter?, Arch Dis Child (Band 87), Seite F75-77.

Buescher, E. S. und Hair, P. S. (2001): Human milk anti-inflammatory component contents during acute mastitis, Cell Immunol (Band 210), Nr. 2, Seite 87-95.

Büscher, E. S. und Malinowska, I. (1996): Soluble receptors and cytokine antagonists in human milk, Pediatr Res (Band 40), Nr. 6, Seite 839-44.

Büscher, E. S. und McWilliams-Koeppen, P. (1998): Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrum and milk bind to TNF-alpha and neutralize TNF-alpha bioactivity, Pediatr Res (Band 44), Nr. 1, Seite 37-42.

Carlström G., Jalling B. (1970): Cytomegalovirus infections in different groups of paediatric patients, Acta Paediatr. Scand (Band 59), Seite 303-309.

Castillo, J. P. und Kowalik, T. F. (2004): Hcmv Infection: Modulating the Cell Cycle and Cell Death, Int Rev Immunol (Band 23), Nr. 1-2, Seite 113-139.

Chang, C. P.; Malone, C. L. und Stinski, M. F. (1989): A human cytomegalovirus early gene has three inducible promoters that are regulated differentially at various times after infection, J Virol (Band 63), Nr. 1, Seite 281-90.

Cherrington, J. M.; Khoury, E. L. und Mocarski, E. S. (1991): Human cytomegalovirus ie2 negatively regulates alpha gene expression via a short target sequence near the transcription start site, J Virol (Band 65), Nr. 2, Seite 887-96.

Chou SW. (1989): Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors, J infect Dis (Band 160), Nr. 1, Seite 11-15.

Clarke NM., May JT. (2000): Effect of antimicrobial factors in human milk on rhinoviruses and milk-borne cytomegalovirus in vitro, J Med Microbiol (Band 49), Seite 719-23.

Compton, T.; Nowlin, D. M. und Cooper, N. R. (1993): Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate, Virology (Band 193), Nr. 2, Seite 834-41.

Cox DB., Owens RA., Hartmann PE. (1996): Blood and milk prolactin and the rate of milk synthesis in women, Exp Physiol. (Band 81), Seite 1007-20.

Dardenne M., de Moraes MC., Kelly PA., Gagnerault MC. (1994): Prolactin Receptor Expression in Human Hematopoietic Tissues analyzed by Flow Cytofluorometry, Endocrinology (Band 134), Seite 2108-2114.

de Graan-Hentzen, Y. C.; Gratama, J. W.; Mudde, G. C.; Verdonck, L. F.; Houbiers, J. G.; Brand, A.; Sebens, F. W.; van Loon, A. M.; The, T. H.; Willemze, R. und et al. (1989): Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products, Transfusion (Band 29), Nr. 9, Seite 757-60.

Döcke, W. D.; Prösch, S.; Fietze, E.; Kimel, V.; Zuckermann, H.; Klug, C.; Syrbe, U.; Kruger, D. H.; von Baehr, R. und Volk, H. D. (1994): Cytomegalovirus reactivation and tumour necrosis factor, Lancet (Band 343), Nr. 8892, Seite 268-9.

Dogusan, Z.; Hooghe, R.; Verdood, P. und Hooghe-Peters, E. L. (2001): Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes, J Neuroimmunol (Band 120), Nr. 1-2, Seite 58-66.

Doniger, J.; Muralidhar, S. und Rosenthal, L. J. (1999): Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate, Clin Microbiol Rev (Band 12), Nr. 3, Seite 367-82.

Doppler, W.; Groner, B. und Ball, R. K. (1989): Prolactin and glucocorticoid hormones synergistically induce expression of transfected rat beta-casein gene promoter constructs in a mammary epithelial cell line, Proc Natl Acad Sci U S A (Band 86), Nr. 1, Seite 1048.

Doppler W., Hock W., Hofer P., Groner b., Ball RK. (1990): Prolactin and glucocorticoid hormones control transcription of the beta-casein gene by kinetically dinstinct mechanisms., Mol Endocrinol, Nr. 4, Seite 912-919.

Doppler W., Welte T., Philipp S. (1995): CCAAT/Enhancer-binding Protein Isoforms B und A are expressed in Mammary Epithelial Cells and bind to multiple Sites in the b-casein Gene Promoter, J. Biol. Chem. (Band 270), Nr. 30, Seite 17962-9.

Dvorak, B.; Fituch, C. C.; Williams, C. S.; Hurst, N. M. und Schanler, R. J. (2003): Increased epidermal growth factor levels in human milk of mothers with extremely premature infants, Pediatr Res (Band 54), Nr. 1, Seite 15-9.

Dworsky M., Stagno S., Pass RF., Cassady G., Alford C. (1982): Persistence of cytomegalovirus in human milk after storage, J Pediatr (Band 101), Seite 440-3.

Dworsky M., Yow M., Stagno S., Pass RF., Alford C. (1983): Cytomegalovirus infection of breast milk and transmission in infancy, Pediatrics (Band 72), Seite 295-9.

Eales-Reynolds, L. J.; Laver, H. und Mojtahedi, H. (2001): Evidence for the expression of the EGF receptor on human monocytic cells, Cytokine (Band 16), Nr. 5, Seite 169-72.

Eglinton BA., Roberton DM., Cummins AG. (1994): Phenotype of T cells, their soluble reeptors levels, and cytokine profile of human breast milk, Immunology and Cell Biology (Band 72), Seite 306.

Fairley JA., Baille J., Bain M., Sinclair JH. (2002): Human cytomegalovirus infection inhibits epidermal growth factor (EGF) signalling by targeting EGF receptors, J. of Gen. Virology (Band 83), Seite 2803-2810.

Fickenscher H., Stamminger T., Rueger R., Felchenstein B. (1989): The Role of a Repetitive Palindromic Sequence Element in the Human Cytomegalovirurs Major Immediate Early Enhancer, J Gen Virol (Band 70), Seite 107-123.

Fietze, E.; Prosch, S.; Reinke, P.; Stein, J.; Docke, W. D.; Staffa, G.; Loning, S.; Devaux, S.; Emmrich, F.; von Baehr, R. und et al. (1994): Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor, Transplantation (Band 58), Nr. 6, Seite 67580.

Fortunato, E. A. und Spector, D. H. (1999): Regulation of human cytomegalovirus gene expression, Adv Virus Res (Band 54), Seite 61-128.

Fries BC., Chou S., Boeckh M., Torok-Strob B. (1994): Frequency distribution of cytomegalovirus Envelope Glycoprotein Genotypes in bone marrow Transplant Recipients, J infect Dis (Band 169), Seite 769-74.

Gawn, J. M. und Greaves, R. F. (2002): Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression, J Virol (Band 76), Nr. 9, Seite 4441-55.

Gerna G., Baldanti F., Zavattoni M., Sarasini A., Percivalle E., Revello MG (1992): Monitoring of ganciclovir sensitivity of multiple human cytomegalovirus strains coinfectiong blood of an AIDS patient by an immediate-early antigen plaque assay, Antivir Res (Band 19), Seite 333-345.

Glaser, R.; Kiecolt-Glaser, J. K.; Speicher, C. E. und Holliday, J. E. (1985): Stress, loneliness, and changes in herpesvirus latency, J Behav Med (Band 8), Nr. 3, Seite 249-60.

Goldblum RM., Dill CW., Albrecht TB., Alford ES., Garza C., Goldman AS. (1984): Rapid high-temperature treatment of human milk, J Pediatr (Band 104), Nr. 380-5.

Goldman AS. (2002): Evolution of the Mammary Gland System and the Ontogeny of the Immune System, Journal of Mammary Gland Biology and Neoplasia (Band 7), Nr. 3, Seite 277-288.

Grattan, M. T.; Moreno-Cabral, C. E.; Starnes, V. A.; Oyer, P. E.; Stinson, E. B. und Shumway, N. E. (1989): Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis, Jama (Band 261), Nr. 24, Seite 3561-6.

Greaves, R. F. und Mocarski, E. S. (1998): Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant, J Virol (Band 72), Nr. 1, Seite 366-79.

Griffiths PD. (2002): Strategies to prevent CMV infection in the neonate, Semin Neonatol (Band 7), Seite 293-299.

Gupta, D. (1983): Hormones and human milk, Endocrinol Exp (Band 17), Nr. 3-4, Seite 359-70.

Hahn, G.; Jores, R. und Mocarski, E. S. (1998): Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells, Proc Natl Acad Sci U S A (Band 95), Nr. 7, Seite 3937-42.

Hamprecht K., Maschmann J., Vochem M., Dietz K., Speer CP., Jahn G. (2001): Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding, Lancet (Band 357), Nr. 513-18.

Hamprecht K., Steinmassl M., Einsele H., Jahn G. (1998 a): Discordant detection of human cytomegalovirus DNA from peripheral blood mononuclear cells, granulocytes and plasma: correlation to viremia and HCMV infection, J Clin Virol (Band 11(2)), Seite 125-36.

Hamprecht K., Vochem M., Baumeister A., Boniek M., Speer CP., Jahn G. (1998 b): Detection of cytomegaloviral DNA in human milk cells and cell free milk whey by nested PCR, J Virol Methods (Band 70), Nr. 167-76.

Hamprecht K., Witzel S., Maschmann J., Speer CP., Jahn G. (2000): Transmission of cytomegalovirus infection through breast milk in term and preterm infants, in:Short and Lomg term Effects of breat feeding on Child Health, Berthold Koletzko, Kluwer Academic /Plenum Publishers.

Hanson, L. A. (1998): Breastfeeding provides passive and likely long-lasting active immunity, Ann Allergy Asthma Immunol (Band 81), Nr. 6, Seite 523-33; quiz 533-4, 537.

Harmsen, M. C.; Swart, P. J.; de Bethune, M. P.; Pauwels, R.; De Clercq, E.; The, T. H. und Meijer, D. K. (1995): Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro, J Infect Dis (Band 172), Nr. 2, Seite 380-8.

Hawkes, J. S.; Bryan, D. L.; James, M. J. und Gibson, R. A. (1999): Cytokines (IL-1beta, IL-6, TNF-alpha, TGF-beta1, and TGF-beta2) and prostaglandin E2 in human milk during the first three months postpartum, Pediatr Res (Band 46), Nr. 2, Seite 194-9.

Hayes K., Gibas H. (1971): Placental cytomegalovirus infection without fetal involment follwing primary infection in pregnancy, J Pediatr (Band 79), Seite 401-405.

He J., Furmanski P. (1995): Sequence specificity and transcritpional activation in the binding of lactoferrin to DNA, Nature (Band 373), Seite 721-24.

Hendrix, M. G.; Salimans, M. M.; van Boven, C. P. und Bruggeman, C. A. (1990): High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis, Am J Pathol (Band 136), Nr. 1, Seite 23-8.

Hertel, L.; Lacaille, V. G.; Strobl, H.; Mellins, E. D. und Mocarski, E. S. (2003): Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus, J Virol (Band 77), Nr. 13, Seite 7563-74.

Hirota K., Muraguchi K., Watabe N., Okumura M., Kozu M., Takahashi K., Machida Y., Funayama Y., Oshima T., Numazaki Y. (1992): Prospective Study on maternal, intrauterine and perinatal infections with Cytomegalovirus in Japan during 1976-1990, J Med Virol (Band 37), Seite 303-306.

Ho M. (1991): Cytomegalovirus: biology and infection (Band New York), Plenum Publ. Corp., New York.

Hotsubo T., Nagata N., Shimada M., Yoshida K., Fujinaga K., Chiba S. (1994): Detection of human cytomeglovirus DNA in breast milk by means of polymerase chain reaction, Microbiol Immunol (Band 38), Seite 809-811.

Hummel, M. und Abecassis, M. M. (2002): A model for reactivation of CMV from latency, J Clin Virol (Band 25 Suppl 2), Seite S123-36.

Hunninghake, G. W.; Monick, M. M.; Liu, B. und Stinski, M. F. (1989): The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements, J Virol (Band 63), Nr. 7, Seite 3026-33.

Isaacs, C. E.; Xu, W.; Kascsak, R. und Pullarkat, R. (2000): Vitamin A in milk can potentially reduce the replication of enveloped viruses in infants, Adv Exp Med Biol (Band 478), Seite 377-8.

Iskenderian, A. C.; Huang, L.; Reilly, A.; Stenberg, R. M. und Anders, D. G. (1996): Four of eleven loci required for transient complementation of human cytomegalovirus DNA replication cooperate to activate expression of replication genes, J Virol (Band 70), Nr. 1, Seite 383-92.

Isomura, H. und Stinski, M. F. (2003): The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection, J Virol (Band 77), Nr. 6, Seite 3602-14.

Jabs D. A., Enger C., Bartlett J. G. (1989): Cytomegalovirus retinitis

and acquired immunodeficiency syndrome, Arch. Ophthalmol. (Band 107), Seite 75–80.

Jesionek, K. (1904): Ueber einen befund von protozoen-artigen gebilden in den organen eines heretitarluetischen foetus, Munch Med Wcohenschr (Band 51), Nr. 1905-1907.

Kahl, M.; Siegel-Axel, D.; Stenglein, S.; Jahn, G. und Sinzger, C. (2000): Efficient lytic infection of human arterial endothelial cells by human cytomegalovirus strains, J Virol (Band 74), Nr. 16, Seite 7628-35.

Kaufmann, R. und Foxman, B. (1991): Mastitis among lactating women: occurrence and risk factors, Soc Sci Med (Band 33), Nr. 6, Seite 701-5.

Keller, M. J.; Wheeler, D. G.; Cooper, E. und Meier, J. L. (2003): Role of the human cytomegalovirus major immediate-early promoter's 19-base-pair-repeat cyclic AMP-response element in acutely infected cells, J Virol (Band 77), Nr. 12, Seite 6666-75.

Klein JM., Fritz BL., McCarthy TA., Wohlford-Lenane CL., Synder JM (1995): Localization of epidermal growth factor receptor in alveolar epithelium during human fetal lung development in vitro, Experimental Lung Research (Band 21), Seite 917-939.

Kline, J. N.; Hunninghake, G. M.; He, B.; Monick, M. M. und Hunninghake, G. W. (1998): Synergistic activation of the human cytomegalovirus major immediate early promoter by prostaglandin E2 and cytokines, Exp Lung Res (Band 24), Nr. 1, Seite 3-14.

Kondo, K. und Mocarski, E. S. (1995): Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors, Scand J Infect Dis Suppl (Band 99), Seite 637.

Kondo, K.; Xu, J. und Mocarski, E. S. (1996): Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals, Proc Natl Acad Sci U S A (Band 93), Nr. 20, Seite 11137-42.

Kourtis, A. P.; Butera, S.; Ibegbu, C.; Beled, L. und Duerr, A. (2003): Breast milk and HIV-1: vector of transmission or vehicle of protection?, Lancet Infect Dis (Band 3), Nr. 12, Seite 786-93.

Krech U. (1973): Complement-fixing antibodies against cytomegalovirus in differnent parts of the world, Bull World Health ORgan (Band 49), Nr. 1, Seite 103.

Kulski, J. K. und Hartmann, P. E. (1981): Changes in the concentration of cortisol in milk during different stages of human lactation, Aust J Exp Biol Med Sci (Band 59), Nr. Pt 6, Seite 769-78.

Kumar, M. L.; Nankervis, G. A.; Jacobs, I. B.; Ernhart, C. B.; Glasson, C. E.; McMillan, P. M. und Gold, E. (1984): Congenital and postnatally acquired cytomegalovirus infections: long-term follow-up, J Pediatr (Band 104), Nr. 5, Seite 674-9.

Kunz, C.; Rodriguez-Palmero, M.; Koletzko, B. und Jensen, R. (1999): Nutritional and biochemical properties of human milk, Part I: General aspects, proteins, and carbohydrates, Clin Perinatol (Band 26), Nr. 2, Seite 307-33.

Laiho, K.; Lampi, A. M.; Hamalainen, M.; Moilanen, E.; Piironen, V.; Arvola, T.; Syrjanen, S. und Isolauri, E. (2003): Breast milk fatty acids, eicosanoids, and cytokines in mothers with and without allergic disease, Pediatr Res (Band 53), Nr. 4, Seite 642-7.

Lamberson HV., Dock NL. (1992): Prevention of transfusion-transmitted cytomegalovirus infection, Transfusion (Band 32), Nr. 1, Seite 196-201.

Lang DJ., Kummer JF (1975): Cytomegalovirus in semen: observation in selected populations, J of infectious diseases (Band 132), Seite 472-472.

Larsson, S.; Soderberg-Naucler, C.; Wang, F. Z. und Moller, E. (1998): Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time, Transfusion (Band 38), Nr. 3, Seite 271-8.

Lathey, J. L. und Spector, S. A. (1991): Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages, J Virol (Band 65), Nr. 11, Seite 6371-5.

Lee, C. H.; Lee, G. C.; Chan, Y. J.; Chiou, C. J.; Ahn, J. H. und Hayward, G. S. (1999): Factors affecting human cytomegalovirus gene expression in human monocyte cell lines, Mol Cells (Band 9), Nr. 1, Seite 37-44.

Lemstrom, K. B.; Bruning, J. H.; Bruggeman, C. A.; Lautenschlager, I. T. und Hayry, P. J. (1993): Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts, J Clin Invest (Band 92), Nr. 2, Seite 549-58.

Leonardi, G. P. und Lipson, S. M. (1992): Enhanced detection of cytomegalovirus in shell vial culture following MRC-5 monolayer pretreatment with glucocorticoids, Zentralbl Bakteriol (Band 277), Nr. 1, Seite 90-9.

Li, F.; Yin, M.; Van Dam, J. G.; Grauls, G.; Rozing, J. und Bruggeman, C. A. (1998): Cytomegalovirus infection enhances the neointima formation in rat aortic allografts: effect of major histocompatibility complex class I and class II antigen differences, Transplantation (Band 65), Nr. 10, Seite 1298-304.

Liu, B. und Stinski, M. F. (1992): Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements, J Virol (Band 66), Nr. 7, Seite 4434-44.

Liu, R.; Baillie, J.; Sissons, J. G. und Sinclair, J. H. (1994): The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells, Nucleic Acids Res (Band 22), Nr. 13, Seite 2453-9.

Lodish H., Baltimore D., Berk A., Zipursky SL., Matudaira P., Darnell J. (1995): Molecular cell biology, W.H. Freeman and Company, New York, 3 rd Edition.

Löffler G., Petrides P. (2003): Biochemie und Pathobiochemie, Thieme Verlag, 7. Auflage.

Lönnerdal B. (2003): Nutritional and physiologic significance of human milk proteins, Am J Nutr. (Band 77).

Lunetta, J. M.; Wiedeman, J. A. (2000): Latency-associated sense transcripts are expressed during in vitro human cytomegalovirus productive infection, Virology (Band 278), Nr. 2, Seite 467-76.

Maidji E., Percivalle E., Gerna G., Fisher S., Pereira L. (2002): Transmission of Human Cytomegalovirus from Infected Uterine Microvasvular Endothelial Cells to Differentiating/Invasinve Placental Cytotrophoblasts, Virology (Band 304), Seite 53-69.

Malone, C. L.; Vesole, D. H. und Stinski, M. F. (1990): Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins, J Virol (Band 64), Nr. 4, Seite 1498-506.

Marchini, A.; Liu, H. und Zhu, H. (2001): Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes, J Virol (Band 75), Nr. 4, Seite 1870-8.

Maschmann J., Hamprecht K., Dietz K., Jahn G., Speer CP. (2001): Cytomegalovirus infection of extremely low-birth weight infants via breast milk, Clin Infect Dis (Band 33), Seite 1998-2003.

Maschmann J., Spper CP., Jahn G. (1999): Inactivation of cytomegalovirus (CMV) in breast milk (Abstract 208), European Society of Paediatric Research, Annual Meeting, 26-29 June. Pediatr Res. 45:924.

McKay, L. I. und Cidlowski, J. A. (1999): Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways, Endocr Rev (Band 20), Nr. 4, Seite 435-59.

Meier, J. L. und Pruessner, J. A. (2000): The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression, J Virol (Band 74), Nr. 4, Seite 1602-13.

Meier, J. L. und Stinski, M. F. (1996): Regulation of human cytomegalovirus immediate-early gene expression, Intervirology (Band 39), Nr. 5-6, Seite 331-42.

Meier, J. L. und Stinski, M. F. (1997): Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells, J Virol (Band 71), Nr. 2, Seite 1246-55.

Meier, J.; Lienicke, U.; Tschirch, E.; Kruger, D. H.; Wauer, R. R. und Prösch, S. (2005): Human cytomegalovirus reactivation during lactation and mother-to-child transmission in preterm infants, J Clin Microbiol (Band 43), Nr. 3, Seite 1318-24.

Melnick, J. L.; Petrie, B. L.; Dreesman, G. R.; Burek, J.; McCollum, C. H. und DeBakey, M. E. (1983): Cytomegalovirus antigen within human arterial smooth muscle cells, Lancet (Band 2), Nr. 8351, Seite 644-7.

Mendelson, M.; Monard, S.; Sissons, P. und Sinclair, J. (1996): Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors, J Gen Virol (Band 77 ( Pt 12)), Seite 3099-102.

Michalsky, M. P.; Lara-Marquez, M.; Chun, L. und Besner, G. E. (2002): Heparin-binding EGF-like growth factor is present in human amniotic fluid and breast milk, J Pediatr Surg (Band 37), Nr. 1, Seite 1-6.

Michie, C. A.; Tantscher, E.; Schall, T. und Rot, A. (1998): Physiological secretion of chemokines in human breast milk, Eur Cytokine Netw (Band 9), Nr. 2, Seite 123-9.

Miettinen, P. J.; Berger, J. E.; Meneses, J.; Phung, Y.; Pedersen, R. A.; Werb, Z. und Derynck, R. (1995): Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor, Nature (Band 376), Nr. 6538, Seite 337-41.

Miettinen, P. J.; Warburton, D.; Bu, D.; Zhao, J. S.; Berger, J. E.; Minoo, P.; Koivisto, T.; Allen, L.; Dobbs, L.; Werb, Z. und Derynck, R. (1997): Impaired lung branching morphogenesis in the absence of functional EGF receptor, Dev Biol (Band 186), Nr. 2, Seite 224-36.

Miller, W. J.; McCullough, J.; Balfour, H. H., Jr.; Haake, R. J.; Ramsay, N. K.; Goldman, A.; Bowman, R. und Kersey, J. (1991): Prevention of cytomegalovirus infection following bone marrow transplantation: a randomized trial of blood product screening, Bone Marrow Transplant (Band 7), Nr. 3, Seite 227-34.

Minder WH. (1953): Die aetiologie der cytomegalia infantium, Schweizer Medizinische Wochenschrift (Band 83), Seite 1180-1182.

Mocarski, E. S., Jr. (2002): Virus self-improvement through inflammation: no pain, no gain, Proc Natl Acad Sci U S A (Band 99), Nr. 6, Seite 3362-4.

Mocarski, E. S.; Kemble, G. W.; Lyle, J. M. und Greaves, R. F. (1996): A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation, Proc Natl Acad Sci U S A (Band 93), Nr. 21, Seite 11321-6.

Mocarski ES., Courcelle T. (2001): Cytomegalovirus and their replication, Knipe, D.; Howley, P., Fields Virology Seite Seiten 2629-2673, Lippincott, Williams and Wilkins, Philadelphia.

Moriuchi H., Moriuchi M. (2001): A milk protein lactoferrin enhances human T cell leukemia virus type 1 and supresses HIV-1 infection, J Immunol (Band 166), Seite 4231-4236.

Moriuchi H., Moriuchi M. (2002): Transforming Growth Factor-beta enhances Human T-cell Leukemia Virus type I Infection, J Med Virol (Band 67), Seite 427-230.

Mosca F., Pugni L., Barbi M., Binda S. (2001): Transmission of cytomegalovirus, Lancet (Band 357), Seite 1800.

Newell ML. (2000): Mother-to-child transmission of cytomegalovirus, in Congenital and perinatal infections, Camvbridge University Press, Eds.: Newell ML. and McIntyre J., Seite 122-134.

Nguyen, D. A.; Parlow, A. F. und Neville, M. C. (2001): Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation, J Endocrinol (Band 170), Nr. 2, Seite 347-56.

Niller, H. H. und Hennighausen, L. (1991): Formation of several specific nucleoprotein complexes on the human cytomegalovirus immediate early enhancer, Nucleic Acids Res (Band 19), Nr. 13, Seite 3715-21.

Nishiguchi Y., Hibasami H., Konada Y., Sakurai M., Nakashima K. (1993): Human promyelocytic cell line HL60 has the specific binding sites for prolactin and its ornithine decarboxylase, DNA synthesis and cellular proliferation are induced by prolactin, Leukemia Research (Band 17), Nr. 8, Seite 633-637.

Numazaki K. (1997): Human cytomegalovirus infection of breast milk, FEMS Immunol MEd Microbiol (Band 18), Seite 91-98.

Ogra, S. S.; Weintraub, D. und Ogra, P. L. (1977): Immunologic aspects of human colostrum and milk. III. Fate and absorption of cellular and soluble components in the gastrointestinal tract of the newborn, J Immunol (Band 119), Nr. 1, Seite 245-8.

Olive DM., Simsek M., Al-Mufti S. (1989): Polymerase chain reaction for detection of human cytomegalovirus, J Clin Microbiol (Band 27), Nr. 6, Seite 1238-42.

Orti, E.; Mendel, D. B.; Smith, L. I. und Munck, A. (1989): Agonist-dependent phosphorylation and nuclear dephosphorylation of glucocorticoid receptors in intact cells, J Biol Chem (Band 264), Nr. 17, Seite 9728-31.

Ost, L.; Wettrell, G.; Bjorkhem, I. und Rane, A. (1985): Prednisolone excretion in human milk, J Pediatr (Band 106), Nr. 6, Seite 1008-11.

Ozar Jasmin. (2002): Untersuchung zur Rolle der cAMP responsive elements im Immediate Early Enhancer des Cytomegalievirus für die stressabhängige Stimulierung, Diplomarbeit.

Paryani SG., Yeager AS., Hosford-Dunn H., Johnson SJ., Malachowski N., Ariagno RL., Stevenson DK. (1985): Sequelae of aquired cytomegalovirus infection in premature and sick term infants, J Pediatr (Band 107), Seite 451-6.

Pass RF. (2001): Cytomegalovirus, Knipe, D.; Howley, P., Fields Virology Seite Seiten 2675-2705, Lippincott, Williams and Wilkins, Philadelphia.

Pass RF., Stagno S., Myers GJ., Alford CA (1980): Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up, Pediatrics (Band 66), Seite 758-62.

Patacchioli, F. R.; Cigliana, G.; Cilumbriello, A.; Perrone, G.; Capri, O.; Alema, G. S.; Zichella, L. und Angelucci, L. (1992): Maternal plasma and milk free cortisol during the first 3 days of breast-feeding following spontaneous delivery or elective cesarean section, Gynecol Obstet Invest (Band 34), Nr. 3, Seite 159-63.

Peckham CS. (1991): Cytomegalovirus infection, congenital and neonatal disease, Scand J Infect Suppl. (Band 78), Seite 82-87.

Peckham CS., Stark O., Dudgeon JA., Martin JAM., Hawkins G. (1987): Congenital cytomegalovirus infection, a cause of sensoneural hearing loss, Arch Dis Child (Band 62), Seite 1233-7.

Pereira L., Maidji E., McDonagh S., Genbacev O., Ma W., Fisher S. (2003): Decidua Functions as a reservoir for transmission of Human Cytomegalovirus to the Placenta in Early Gestation, Vortrag im Rahmen des 9. Intern Cytomegalovirus Workshop (Maastricht, 20-25 Mai 2003).

Picard, D. und Yamamoto, K. R. (1987): Two signals mediate hormone-dependent nuclear localization of the glucocorticoid receptor, Embo J (Band 6), Nr. 11, Seite 3333-40.

Plachter B., Sinzger C., Jahn G. (1996): Cell types involved in replication and distribution of human cytomegalovirus, Adv Virus Res (Band 46), Seite 195-261.

Portelli, J.; Gordon, A. und May, J. T. (1998): Effect of compounds with antibacterial activities in human milk on respiratory syncytial virus and cytomegalovirus in vitro, J Med Microbiol (Band 47), Nr. 11, Seite 1015-8.

Pratt, W. B. (1993): The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor, J Biol Chem (Band 268), Nr. 29, Seite 214558.

Prix, L.; Kuner, R.; Speer, C. P.; Jahn, G. und Hamprecht, K. (1998): Evaluation of restriction fragment length polymorphism analysis of the UL10-UL13 genomic region for rapid identification of human cytomegalovirus strains, Eur J Clin Microbiol Infect Dis (Band 17), Nr. 7, Seite 525-8.

Prösch S., Docke WD., Reinke P., Volk HD., Kruger DH. (1999): Human cytomegalovirus reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and mature monocytes, Intervirology (Band 42), Nr. 5-6, Seite 308-13.

Prösch S., Heine AK., Volk HD., Kruger DH. (2001): CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation, Biol Chem (Band 276), Nr. 44, Seite 40712-20.

Prösch S., Kimel V., Dawydowa I., Kruger DH. (1992): Monitoring of patients for cytomegalovirus after organ transplantation by centrifugation culture and PCR., J Med Virol (Band 38), Nr. 4, Seite 246-51.

Prösch S., Lienicke U., Priemer C., Flunker G., Seidel WF., Kruger DH., Wauer RR. (2002 b): Human adenovirus and human cytomegalovirus infections in preterm newborns: no association with bronchopulmonary dysplasia, Pediatr Res (Band 52), Nr. 2, Seite 21924.

Prösch S., Reinke P., Volk HD., Kruger DH. (2000 b): Cytomegalovirus infections in patients after organ transplantation. Epidemiology, diagnosis, therapy, Internist (Band 31), Nr. 11, Seite 1253-60.

Prösch S., Staak K., Stein J., Liebenthal C., Stamminger T., Volk HD., Kruger DH. (1995): Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB, Virology (Band 208), Nr. 1, Seite 197-206.

Prösch, S.; Wendt, C. E.; Reinke, P.; Priemer, C.; Oppert, M.; Kruger, D. H.; Volk, H. D. und Docke, W. D. (2000 a): A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation, Virology (Band 272), Nr. 2, Seite 357-65.

Prösch S., Wendt C., Wuttke R., Beutler T., Asadullah K., Krueger DH., Volk HD (eingereicht): Glucocorticoid stimulation of human cytomegalovirus replication: Identification of functional active glucocorticoid receptor responsive elements (GRE) in the human cytomegalovirus IE1/2 enhancer stimulated by trans-activating properties of glucocorticoids, in press.

Prösch S., Wuttke R., Kruger DH., Volk HD. (2002): NF-kappaB--a potential therapeutic target for inhibition of human cytomegalovirus (re)activation?, Biol Chem (Band 383), Nr. 10, Seite 1601-9.

Rahbar, A. R.; Sundqvist, V. A.; Wirgart, B. Z.; Grillner, L. und Soderberg-Naucler, C. (2004): Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors, Transfusion (Band 44), Nr. 7, Seite 1059-66.

Ramsey MEB., Miller E., Peckham CS. (1991): Outcome of confirmed symptomatic congenital cytomegalovirus infection, Arch Dis Child (Band 66), Seite 1068-9.

Read LC., Upton FM., Francis GL., Wallace JC., Dahlenberg GW, Ballard FJ. (1984): Changes in the growth-promoting acitivity of human milk during laktation, Pediatr Res (Band 18), Seite 133-139.

Reinke, P.; Fietze, E.; Ode-Hakim, S.; Prosch, S.; Lippert, J.; Ewert, R. und Volk, H. D. (1994): Late-acute renal allograft rejection and symptomless cytomegalovirus infection, Lancet (Band 344), Nr. 8939-8940, Seite 1737-8.

Revello MG. (2003): Pathogenesis of congenital HCMV infection, Vortrag im Rahmen des 9. Intern Cytomegalovirus Workshop (Maastricht, 20-25 Mai 2003).

Reynolds DW., Stagno S., Hosty TS., Tiller M., Alford CA Jr. (1973): Maternal cytomegalovirus exrection and perinatal infection, N Engl J Med (Band 289), Seite 1-5.

Rodriguez-Palmero, M.; Koletzko, B.; Kunz, C. und Jensen, R. (1999): Nutritional and biochemical properties of human milk: II. Lipids, micronutrients, and bioactive factors, Clin Perinatol (Band 26), Nr. 2, Seite 335-59.

Rowe WP., Hartley JW., Waterman S., et al (1956): Cytopathogenic agent resembling salivery gland virus recovered from tissue cultures of human adenoids, Proc Soc Exp Biol Med (Band 92), Seite 418-424.

Rubin, R. H. (1990): Impact of cytomegalovirus infection on organ transplant recipients, Rev Infect Dis (Band 12 Suppl 7), Seite S754-66.

Rudloff, H. E.; Schmalstieg, F. C., Jr.; Mushtaha, A. A.; Palkowetz, K. H.; Liu, S. K. und Goldman, A. S. (1992): Tumor necrosis factor-alpha in human milk, Pediatr Res (Band 31), Nr. 1, Seite 29-33.

Saito S., Yoshida M., Ichijo M., Ishizaka S., Tsuji T. (1994): Transforming growth factor-beta in human milk, Clin Exp Immunol, Seite 220-224.

Samanta, M.; Harkins, L.; Klemm, K.; Britt, W. J. und Cobbs, C. S. (2003): High Prevalence of Human Cytomegalovirus in Prostatic Intraepithelial Neoplasia and Prostatic Carcinoma, J Urol (Band 170), Nr. 3, Seite 998-1002.

Sambucetti LC., Cherrington JM., Wilkinson GW., Mocarski ES (1989): NF-kappa B activation of cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation, EMBO (Band 8), Nr. 13, Seite 4251-8.

Semba, R. D.; Kumwenda, N.; Hoover, D. R.; Taha, T. E.; Quinn, T. C.; Mtimavalye, L.; Biggar, R. J.; Broadhead, R.; Miotti, P. G.; Sokoll, L. J.; van der Hoeven, L. und Chiphangwi, J. D. (1999): Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1, J Infect Dis (Band 180), Nr. 1, Seite 93-8.

Sharland M., Khare M., Bedford-Russell A. (2002): Prevention of postnatal cytomegalovirus infection in preterm infants, Arch Dis Child Fetal Neonatal Ed (Band 86), Seite f140.

Sinclair, J. und Sissons, P. (1996): Latent and persistent infections of monocytes and macrophages, Intervirology (Band 39), Nr. 5-6, Seite 293-301.

Sinzger, C. und Jahn, G. (1996): Human cytomegalovirus cell tropism and pathogenesis, Intervirology (Band 39), Nr. 5-6, Seite 302-19.

Sinzger, C.; Muntefering, H.; Loning, T.; Stoss, H.; Plachter, B. und Jahn, G. (1993): Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining, Virchows Arch A Pathol Anat Histopathol (Band 423), Nr. 4, Seite 249-56.

Sissons, J. G.; Bain, M. und Wills, M. R. (2002): Latency and reactivation of human cytomegalovirus, J Infect (Band 44), Nr. 2, Seite 73-7.

Slobedman, B. und Mocarski, E. S. (1999): Quantitative analysis of latent human cytomegalovirus, J Virol (Band 73), Nr. 6, Seite 4806-12.

Smith, D. F. und Toft, D. O. (1993): Steroid receptors and their associated proteins, Mol Endocrinol (Band 7), Nr. 1, Seite 4-11.

Smith MG. (1956): Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease, Proc Soc Exp Biol Med (Band 92), Seite 424-430.

Soderberg-Naucler C., Fish KN., Nelson JA. (1997): Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors, Cell (Band 91), Nr. 1, Seite 119-26.

Soderberg-Naucler C., Streblow DN., Fish KN., Allan-Yorke J., Smith PP., Nelson JA. (2001): Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent, J Virol (Band 75), Nr. 16, Seite 7543-54.

Son KN., Park J., Chung CK., Chung DK., Yu DY., Lee KK., Kim J. (2002): Human lactoferrin activates transcription of IL-1 beta gene in mammalian cells, Biochem Biophys Res Commun (Band 290), Seite 236-41.

Sone, S.; Tsutsumi, H.; Takeuchi, R.; Matsuda, K.; Imai, S.; Ogra, P. L. und Chiba, S. (1997): Enhanced cytokine production by milk macrophages following infection with respiratory syncytial virus, J Leukoc Biol (Band 61), Nr. 5, Seite 630-6.

Spano, L. C.; Gatti, J.; Nascimento, J. P. und Leite, J. P. (2004): Prevalence of human cytomegalovirus infection in pregnant and non-pregnant women, J Infect (Band 48), Nr. 3, Seite 213-20.

Spano, L. C.; Vargas, P. R.; Ribeiro, F. S.; Leite, J. P. und Nascimento, J. P. (2002): Cytomegalovirus in human abortion in Espirito Santo, Brazil, J Clin Virol (Band 25 Suppl 2), Seite S173-8.

St George, K. und Rinaldo, C. R., Jr. (1994): Effects of enhancing agents on detection of cytomegalovirus in clinical specimens, J Clin Microbiol (Band 32), Nr. 8, Seite 2024-7.

Staak, K.; Prosch, S.; Stein, J.; Priemer, C.; Ewert, R.; Docke, W. D.; Kruger, D. H.; Volk, H. D. und Reinke, P. (1997): Pentoxifylline promotes replication of human cytomegalovirus in vivo and in vitro, Blood (Band 89), Nr. 10, Seite 3682-90.

Stagno S., Cloud AC. (1994): Working parents: The impact of day care an breast-feeding on cytomegalovirus infections in offspring, Proc Natl. Acad. Science (Band 91), Seite 23842389.

Stagno S., Pass RF., Cloud G., Britt WJ., Henderson RE., Walton PD., Veren DA., Page F., Alford CA. (1986): Primary cytomgalovirus infection in pregnany. Incidence, transmission to fetus, and clinical outcome, JAMA (Band 356), Seite 1904-1908.

Stagno S., Pass RF., Dwosky ME., Alford CA. (1983): Congenital and perinatal cytomegalovirus infections, Semin. Perinatol (Band 7), Seite 31-42.

Stagno S., Reynolds DW., Pass RF., Alford CA. (1980): Breast milk and the risk of cytomegalovirus infection, N Engl J Med (Band 302), Seite 1073-6.

Stagno S., Reynolds DW., Tsiantos A., Fuccillo DA., Smith R., Tiller M., Alford CA. (1975): Cervical Cytomegalovirus excretion in pregnant an nonpregnant women: supression in early gestation, J of infectious diseases (Band 131), Nr. 5, Seite 533-527.

Stamminger, T.; Fickenscher, H. und Fleckenstein, B. (1990): Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP, J Gen Virol (Band 71 ( Pt 1)), Seite 105-13.

Stamminger, T.; Gstaiger, M.; Weinzierl, K.; Lorz, K.; Winkler, M. und Schaffner, W. (2002): Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain, J Virol (Band 76), Nr. 10, Seite 4836-47.

Stein J., Volk HD., Liebenthal C., Kruger DH., Prosch S. (1993): Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells, J Gen Virol (Band 74), Nr. 11, Seite 2333-8.

Stern H., Friedman I. (1960): Intranuclear formation of cytomegalovirus inclusion disease virus, Nature (Band 188), Seite 768-770.

Stöcklin, E.; Wissler, M.; Moriggl, R. und Groner, B. (1997): Specific DNA binding of Stat5, but not of glucocorticoid receptor, is required for their functional cooperation in the regulation of gene transcription, Mol Cell Biol (Band 17), Nr. 11, Seite 6708-16.

Stratton KR., Durch JS., Lawrence RS. (2000): Vaccines for the 21st Century, Nat. Acad. Press.

Taetle, R.; Oval, J.; Smedsrud, M.; Davis, C. und Gansbacher, B. (1991): Analysis of granulocyte-macrophage colony-stimulating factor action in differentiating myeloid leukemia cells: treatment with DMSO may reveal a common pathway for growth factor gene regulation, Exp Hematol (Band 19), Nr. 3, Seite 213-20.

Takahata, Y.; Takada, H.; Nomura, A.; Ohshima, K.; Nakayama, H.; Tsuda, T.; Nakano, H. und Hara, T. (2001): Interleukin-18 in human milk, Pediatr Res (Band 50), Nr. 2, Seite 26872.

Tanaka, J.; Ogura, T.; Kamiya, S.; Yoshie, T.; Yabuki, Y. und Hatano, M. (1984 a): Dexamethasone enhances human cytomegalovirus replication in human epithelial cell cultures, Virology (Band 136), Nr. 2, Seite 448-52.

Tanaka J., Ogura T., Kamiya S., Sato H., Yoshie D., Ogura H., Hatano M. (1984 b): Enhanced Replication of Human Cytomegalovirus in Human Fibroblasts treated with Dexamethason, J Gen Virol (Band 65), Seite 1759-1767.

Taylor-Wiedeman, J.; Sissons, J. G.; Borysiewicz, L. K. und Sinclair, J. H. (1991): Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells, J Gen Virol (Band 72 ( Pt 9)), Seite 2059-64.

Taylor-Wiedeman, J.; Sissons, P. und Sinclair, J. (1994): Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers, J Virol (Band 68), Nr. 3, Seite 1597-604.

Toniolo, A.; Serra, C.; Conaldi, P. G.; Basolo, F.; Falcone, V. und Dolei, A. (1995): Productive HIV-1 infection of normal human mammary epithelial cells, Aids (Band 9), Nr. 8, Seite 859-66.

Toro, A. I. und Ossa, J. (1996): PCR activity of CMV in healthy CMV-seropositive individuals: does latency need redefinition?, Res Virol (Band 147), Nr. 4, Seite 233-8.

Van de Perre, P. (2003): Transfer of antibody via mother's milk, Vaccine (Band 21), Nr. 24, Seite 3374-6.

van der Hoof, J.A.; Zach, T.L.; Adrian, T.E. (1994): Gastrointestinal diseases, Avery, G.B.; Fletcher, M.A.; McDonald, M.G., Neonatology, Pathophysiology and Management of the newborn, 4. Auflage. Auflage, Seite 206, J. B. Lippincott Company.

van der Strate BW., Harmsen MC., Schafer P., Swart PJ., The TH., Jahn G., Speer CP., Meijer DK., Hamprecht K. (2001): Viral Load in breast milk correlates with transmission of human cytomegalovirus to preterm neonates but lactoferrin concentrations do not, Clinical and diagnostic laboratory immunology (Band 8), Nr. 4, Seite 818-21.

Vochem, M. (2003): [CMV infections of the neonate: prevalence, diagnosis, therapy], Z Geburtshilfe Neonatol (Band 207), Nr. 3, Seite 114-8.

Vochem M., Hamprecht K., Jahn G., Speer CP. (1998): Transmission of cytomegalovirus to preterm infants throught breast milk, Pediatr Infect Dis J (Band 17), Seite 53-8.

Vogelberg C., Meyer-König U., Hufert FT., Kirste G., von Laer D. (1996): Human Cytomegalovirus Glycoprotein B Genotypes in Renal transplant recipients, J Med Virol (Band 50), Seite 31-34.

Vollmer, B.; Seibold-Weiger, K.; Schmitz-Salue, C.; Hamprecht, K.; Goelz, R.; Krageloh-Mann, I. und Speer, C. P. (2004): Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants, Pediatr Infect Dis J (Band 23), Nr. 4, Seite 322-327.

von Glahn WC., Pappenheimer AM. (1925): Intranuclear inclusions in visceral disease, American Journal of Pathology, Nr. 1, Seite 445-465.

Wallace, J. M.; Ferguson, S. J.; Loane, P.; Kell, M.; Millar, S. und Gillmore, W. S. (1997): Cytokines in human breast milk, Br J Biomed Sci (Band 54), Nr. 2, Seite 85-7.

Wang, X.; Huong, S. M.; Chiu, M. L.; Raab-Traub, N. und Huang, E. S. (2003): Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus, Nature (Band 424), Nr. 6947, Seite 456-61.

Wathen, M. W. und Stinski, M. F. (1982): Temporal patterns of human cytomegalovirus transcription: mapping the viral RNAs synthesized at immediate early, early, and late times after infection, J Virol (Band 41), Nr. 2, Seite 462-77.

Weller TH., Macauley JC., Craig JM., Wirth P. (1957): Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease, Proc Soc Exp Biol Med (Band 94), Seite 4-12.

Willumsen, J. F.; Filteau, S. M.; Coutsoudis, A.; Newell, M. L.; Rollins, N. C.; Coovadia, H. M. und Tomkins, A. M. (2003): Breastmilk RNA viral load in HIV-infected South African women: effects of subclinical mastitis and infant feeding, Aids (Band 17), Nr. 3, Seite 407-14.

Xanthou, M. (1997): Human milk cells, Acta Paediatr (Band 86), Nr. 12, Seite 1288-90.

Yasuda A., Kimura H., Hayakawa M., Ohshiro M., Kato Y., Matsuura O., Suzuki C. Morishima T. (2003): Evaluation of Cytomegalovirus Infections transmitted via breast milk in preterm infants with a real-time Polymerase Chain reaction Essay, Pediatr (Band 111), Nr. 6, Seite 1333-36.

Yeager, A. S.; Palumbo, P. E.; Malachowski, N.; Ariagno, R. L. und Stevenson, D. K. (1983): Sequelae of maternally derived cytomegalovirus infections in premature infants, J Pediatr (Band 102), Nr. 6, Seite 918-22.

Yuen, Ho (1988): Prolactin in human milk: influence of nursing and the duration of postpartum lactation, Am J Obstet Gynecol (Band 158), Seite 583-6.

Zwiauer, K.; Duetsch, J.; Goriup, U.; Haas, H.; Haiden, N.; Holzmann, H.; Pietschnig, B.; Pollak, A.; Popow, T.; Rock, I.; Sperl, W. und Widhalm, K. (2003): Prävention von Muttermilch-mediierten CMV-Infektionen bei Frühgeborenen, Monatschrift Kinderheilkunde (Band 12), Seite 1346-47.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
31.07.2006